Zyvox Dose Adjustments Not Necessary For Renally Impaired Patients - P&U
Executive Summary
Pharmacia & Upjohn maintains that no Zyvox (linezolid) dose adjustment is necessary to treat patients with renal dysfunction despite accumulation of two linezolid metabolites.
You may also be interested in...
Zyvox Phase IV Studies May Support Penicillin-Resistant Indications
Pharmacia will continue to seek additional indications for Zyvox (linezolid) in the treatment of antibiotic-resistant infections.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011